Impact of growth hormone therapy on quality of life in adults with turner syndrome

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 3, 2010, Pages 1355-1359

  Amundson, Emily ^a   Boman, Ulla Wide ^b   Barrenäs, Marie Louise ^a   Bryman, Inger ^a   Landin Wilhelmsen, Kerstin ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE; OXANDROLONE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BONE DENSITY; BONE MINERAL; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOCARDIOGRAPHY; FEMALE; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; OVARY INSUFFICIENCY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; QUALITY OF LIFE; QUESTIONNAIRE; SHORT STATURE; SOCIAL ISOLATION; SWEDEN; TREATMENT OUTCOME; TURNER SYNDROME; WELLBEING;

EID: 77749233817     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1754     Document Type: Article

References (18)

1. Sybert VP, McCauley E 2004 Turners syndrome. N Engl J Med 351:1227-1238
2. El-Mansoury M, Barrenäs ML, Bryman I, Hanson C, Larsson C, Wilhelmsen L, Landin-Wilhelmsen K 2007 Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in Turner syndrome. Clin Endocrinol (Oxf) 66:744-751
3. Landin-Wilhelmsen K, Bryman I, Wilhelmsen L 2001 Cardiac malformations and hypertension, but not metabolic risk factors, are common in Turner syndrome. J Clin Endocrinol Metab 86: 4166-4170
4. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K 2005 Hypothyroidism is common in Turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab 90:2131-2135
5. Anderson H, Filipsson R, Fluur, E, Lindsten J, Wedenberg E 1969 Hearing impairment in Turner's syndrome. Acta Otolaryngol 247:1-26
6. Barrenäs M, Landin-Wilhelmsen K, Hanson C 2000 Ear and hearing in relation to genotype and growth in Turner syndrome. Hear Res 144:21-28
7. El-Mansoury M, Barrenäs ML, Bryman I, Hanson C, Landin-Wilhelmsen K 2009 Impaired body balance, fine motor function and hearing in women with Turner syndrome. Clin Endocrinol (Oxf) 71:273-278
8. Landin-Wilhelmsen K, Bryman I, Windh M, Wilhelmsen L 1999 Osteoporosis and fractures in Turner syndrome - importance of growth promoting and oestrogen therapy. Clin Endocrinol (Oxf) 51:497-502
9. Rovet JF 1993 The Psychoeducational characteristics of children with Turner syndrome. J Learn Disabil 26:333-341
10. Wide-Boman UW, Bryman I, Halling K, Möller A 2001 Women with Turner syndrome: psychological well being, self related health and social life. J Psychosom Obstet Gynaecol 22:113-122
11. Wilhelmsen L, Johansson S, Rosengren A, Wallin I, Dotevall A, Lappas G 1997 Risk factors for cardiovascular disease during the period 1985-1995 in Gothenburg, Sweden. The GOT-MONICA project. J Intern Med 242:199-211
12. Dupuy HJ 1984 The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson MF, Furberg CF, Elinson J, eds. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing Inc.; 170-183
13. Wiklund I 1990 The Nottingham Health Profile - a measure of health-related quality of life. Scand J Prim Health Care Suppl 1:15-18
14. Bondy CA for The Turner Syndrome Consensus Study Group 2007 Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 92:10-25
15. Hull KL, Harvey S 2003 Growth hormone therapy and quality of life: possibilities, pitfalls and mechanisms. J Endocrinol 179: 311-333
16. Carel JC, Ecosse E, Bastie-Sigeac I, Cabrol S, Tauber M, Léger J, Nicolino M, Brauner R, Chaussain JL, Coste J 2005 Quality of life determinants in young women with Turner's syndrome after growth hormone treatment: Results of the StaTur population-based cohort study. J Clin Endocrinol Metab 90:1992-1997
17. Ross JL 2005 Effects of growth hormone on cognitive function. Horm Res 64:89-94
18. Baxter L, Bryant J, Cave CB, Milne R 2007 Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev 3:CD003887